Evidence map›Paper›PMID 31934063›Full record

ArticleInternational journal of clinical and experimental pathology2019

The efficacy of

Xufu Wang, Xiaokun Hu, Xinfeng Liu, Lijing Peng, Zenghua Wang, Guoqiang Wang, Guoming Wang, Qin Zhang, Jiankui Han

Abstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xufu WangDepartment of Nuclear Medicine, The Affiliated Hospital of Qingdao University Qingdao 266003, Shandong, China.
Xiaokun HuThe Centre of Intervention, The Affiliated Hospital of Qingdao University Qingdao 266003, Shandong, China.
Xinfeng LiuDepartment of Nuclear Medicine, The Affiliated Hospital of Qingdao University Qingdao 266003, Shandong, China.
Lijing PengDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University Qingdao 266003, Shandong, China.
Zenghua WangDepartment of Nuclear Medicine, The Affiliated Hospital of Qingdao University Qingdao 266003, Shandong, China.
Guoqiang WangDepartment of Nuclear Medicine, The Affiliated Hospital of Qingdao University Qingdao 266003, Shandong, China.
Guoming WangDepartment of Nuclear Medicine, The Affiliated Hospital of Qingdao University Qingdao 266003, Shandong, China.
Qin ZhangDepartment of Nuclear Medicine, The Affiliated Hospital of Qingdao University Qingdao 266003, Shandong, China.
Jiankui HanDepartment of Nuclear Medicine, Qilu Hospital of Shandong University Shandong, China.
Qingdao University · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the efficacy of

methodsTwelve New Zealand white rabbit VX2 liver cancer models were successfully prepared by tumor cell suspension method and randomly divided into a control group and treatment group. The treatment group received

resultsThe T/N ratio, ER, and DR showed no statistical changes following the implantation time in the control group. In the treatment group, ER and DR gradually decreased after implantation of

conclusionThis method has value in evaluating the efficacy of

Indexed as

125I particle99mTc-MIBI imagingefficacy evaluationinterstitial implantationliver cancer modelVX2 tumor

Identifiers

PMID31934063
PMCPMC6949617
OpenAlexW3028145908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.